Bausch Health Companies Inc. (BHC)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Salix Revenue	2.52B	2.33B	2.25B
Salix Revenue Growth	7.97%	3.69%	7.66%
International Rx Revenue	1.11B	1.11B	1.07B
International Rx Revenue Growth	-0.54%	3.74%	8.40%
Solta Medical Revenue	519.00M	440.00M	347.00M
Solta Medical Revenue Growth	17.95%	26.80%	15.67%
Diversified Products Revenue	910.00M	950.00M	943.00M
Diversified Products Revenue Growth	-4.21%	0.74%	-3.58%
Bausch + Lomb Revenue	4.98B	4.79B	4.15B
Bausch + Lomb Revenue Growth	3.86%	15.56%	10.03%
Revenue (Other)	-755.58M	-	-
Revenue (Total)	9.27B	9.63B	8.76B
Revenue (Total) Growth	-3.65%	9.91%	7.79%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Salix Segment Profit	1.86B	1.60B	1.55B
Salix Segment Profit Growth	15.86%	3.49%	3.96%
International Rx Segment Profit	351.00M	376.00M	335.00M
International Rx Segment Profit Growth	-6.65%	12.24%	3.40%
Solta Medical Segment Profit	250.00M	213.00M	161.00M
Solta Medical Segment Profit Growth	17.37%	32.30%	19.26%
Diversified Products Segment Profit	605.00M	626.00M	586.00M
Diversified Products Segment Profit Growth	-3.36%	6.83%	-4.25%
Bausch + Lomb Segment Profit	1.04B	1.11B	980.00M
Bausch + Lomb Segment Profit Growth	-6.32%	13.06%	12.13%
Operating Income (Total)	1.72B	1.55B	963.00M
Operating Income (Total) Growth	11.42%	60.54%	112.12%

Updated Sep 30, 2025. Data Source: Fiscal.ai.